Hirotaka Hoshi

An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids

Nobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa et al. · Cells · 2019 · 80 citations · Full text

Medicine, Oncology, Pharmacology +16

Isolation and Characterization of a Novel Immunomodulatory α-Glucan−Protein Complex from the Mycelium of<i>Tricholoma matsutake</i>in Basidiomycetes

Hirotaka Hoshi, Yoko Yagi, Hiroko Iijima et al. · Journal of Agricultural and Food Chemistry · 2005 · 70 citations

Life Sciences, Biology, Immunology +16

Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues

Hirosumi Tamura, Arisa Higa, Hirotaka Hoshi et al. · Oncology Reports · 2018 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +12

MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways

Hirotaka Hoshi, Tetsuji Sawada, Motoyuki Uchida et al. · International Journal of Oncology · 2013 · 40 citations · Full text

Life Sciences, Immunology, Oncology +15

Absorption and Tissue Distribution of an Immunomodulatory α-<scp>d</scp>-Glucan after Oral Administration of Tricholoma matsutake

Hirotaka Hoshi, Hiroko Iijima, Yoko Ishihara et al. · Journal of Agricultural and Food Chemistry · 2008 · 25 citations

Pharmacy, Pharmacokinetics, Pharmacology +15